Efficacy and safety results from a phase I/IIa study of dabrafenib in pediatric patients with BRAF V600-mutant relapsed refractory low-grade glioma Meeting Abstract
| Authors: | Kieran, M. W.; Bouffet, E.; Broniscer, A.; Cohen, K. J.; Geoerger, B.; Hansford, J. R.; Hingorani, P.; Aerts, I.; Andre, N.; Bertozzi-Salamon, A. I.; Dunkel, I. J.; Hummel, T. R.; Leary, S.; Moreno, L.; Russo, M. W.; Tseng, L.; Dasgupta, K.; Nebot, N.; Whitlock, J.; Hargrave, D. R. |
| Abstract Title: | Efficacy and safety results from a phase I/IIa study of dabrafenib in pediatric patients with BRAF V600-mutant relapsed refractory low-grade glioma |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 551s |
| Language: | English |
| ACCESSION: | WOS:000442916003495 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.10506 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 10506 -- Source: Wos |
